| Falk, Ursula (Dr Falk Pharma 201403 Managing Director) |
Managing Director |
Falk Pharma (Group) |
Germany |
| Falken, Ulrich (Analyticon Biotechnologies 2007 COO) |
Chief Operating Officer (COO) |
Analyticon Biotechnologies AG |
Germany |
| Falkstedt (formerly Santoni), Marjut (EU (govt) 202301– Chief Executive of European Investment Fund joined EU 1996) |
Chief Executive Officer (CEO) |
EU (govt) |
Luxembourg |
| Fallegger, Florian (Neurosoft Bioelectronics 202103 CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
Neurosoft Bioelectronics (CH) |
Switzerland |
| Fallen, Karen (Touchlight 202010– CEO of Touchlight DNA Servcies before Lonza + Celltech) |
Chief Executive Officer (CEO) |
Touchlight (Group) |
United Kingdom (GB) |
| Fambrough, Douglas M. (Dicerna Pharmaceuticals 201711 CEO) |
Chief Executive Officer (CEO) |
Dicerna Pharmaceuticals Inc. (Nasdaq: DRNA) |
United States (USA) |
| Fang, Guowei (GenScript 202311 CSO + Head of Business Development at Legend Biotech) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
GenScript (Group) |
United Kingdom (GB) |
| Fang, Nan (Singleron 202203 CEO + Co-Founder before Novogene + Qiagen) |
Chief Executive Officer (CEO) |
Singleron (Group) |
China |
| Fang, Peter (Boehringer 202002 SVP + Head of Therapeutic Area Inflammation) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Fang, Yongliang (Doer Biologics 202307 COO) |
Chief Operating Officer (COO) |
Doer Biologics (Group) |
China |
| Faraco, Vincenza (University of Naples Federico II 201405) |
Researcher (university / research institute) |
University of Naples Federico II |
Italy |
| Farhangi, Sonja (Stratec 201110 Stratec Molecular GmbH Marketing + Public Relations) |
Sales Manager / Marketing Manager |
Stratec (Group) |
Germany |
| Farid, Ramy (Schrödinger 202011 CEO) |
Chief Executive Officer (CEO) |
Schrödinger (Group) |
United States (USA) |
| Farinelli, Laurent (Fasteris 200901 CEO + co-founder |
Chief Executive Officer (CEO) |
Fasteris S.A. |
Switzerland |
| Farmer, Jeffrey (Brooks Automation 201307 VP + General Manager of Brooks Life Science Systems) |
General Manager (management) |
Azenta (Group) |
United States (USA) |
| Farnum, Andrew (Variant Bio 202404 CEO) |
Chief Executive Officer (CEO) |
Variant Bio Inc. |
United States (USA) |
| Farre, Cecilia (Nanion 201309 Marketing Director) |
Sales Manager / Marketing Manager |
Nanion (Group) |
Germany |
| Farzan, Nima (PaxVax 201507 CEO) |
Chief Executive Officer (CEO) |
PaxVax (Group) |
United States (USA) |
| Fasbender, Stefan (High-Tech Gründerfonds 202101) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Fasler, Stephan (Exquiron Biotech AG 201502 CEO) |
Chief Executive Officer (CEO) |
Evotec (Group) |
Switzerland |
| Fastenau, Robin (Metabolon 201409 VP Corporate Marketing + Communications) |
Sales Manager / Marketing Manager |
Metabolon (Group) |
United States (USA) |
| Fath, Andreas (Univ Furtwangen 201411 Professor) |
Professor |
Hochschule Furtwangen University (HFU) |
Germany |
| Fathi, Marc (University Geneva 201008 HUG Toxicology Lab) |
Researcher (university / research institute) |
University of Geneva (Université de Genève, UNIGE) |
Switzerland |
| Fatscher, Hans Peter (Qiagen 201710– VP + Head of Qiagen Custom Solutions business) |
President/Director/Head Business Group/Unit/Division |
Qiagen Custom Solutions (business unit) |
|
| Faulstich, Konrad (201011 Director Strategic Alliances before ESE GmbH 200909 Head BusDev) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
| Faupel, Tobias (Germany (govt) 202409 Managing Director at DeepTech & Climate Fonds) |
Managing Director |
Germany (govt) |
Germany |
| Faure, Alexia (NewCap 201705– Consultant before Hume Brophy since 201409) |
Public Relations Manager / Investor Relations Manager |
NewCap. – Investor Relations & Financial Communications |
France |
| Faus, Ignacio (NFL Biosciences 202106 CEO before Mologen 201808–201903 CEO before Palau Pharma) |
Chief Executive Officer (CEO) |
Mologen (Group) |
Germany |
| Faust, Nicole (Cevec 201904 CEO + CSO joined Cevec 201105 before amaxa + Artemis Pharmaceuticals) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Danaher (Group) |
Germany |
| Fayolle, Ambroise (EU (govt) 201607 VP of EIB) |
n. a. |
EU (govt) |
Luxembourg |
| Faßmann, Heinz (Austrian Academy of Sciences 202403 President) |
President/Director/Head of Research Organisation/Unit |
Austrian Academy of Sciences (Österreichische Akademie der Wissenschaften, ÖAW) |
Austria |
| Federer, Werner (V&F 201103 President) |
President/Director/Head Business Group/Unit/Division |
V&F (Group) |
Austria |
| Fedunik, Olivia (Prefound GmbH 201501 Managing Director) |
Managing Director |
Prefound GmbH |
Germany |
| Feger, Dieter (MorphoSys 200901 Head AbD Serotec business before Abbott Diagnostics Marketing Director Global Marketing) |
General Manager (management) |
Bio-Rad (Group) |
Germany |
| Fehlmann, Simona (Sallea 202311– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Sallea AG |
Switzerland |
| Fehmer, Jürgen (Geneworx AG) |
n. a. |
Geneworx AG |
Germany |
| Fehr, Markus (Ayoxxa 202203– Co-CEO + existent China Representative of GHA Germany Health Alliance) |
Chief Executive Officer (CEO) |
Ayoxxa (Group) |
Germany |
| Fehr, Matthias (HBM Partners 202105 Head of Private Equity) |
Investment Manager |
HBM (Group) |
Switzerland |
| Fei, Dr. (Techpool Bio-Pharma 1993– Founder + CEO) |
Chief Executive Officer (CEO) |
Takeda (Group) |
China |
| Feig, Francois (Merck Serono 200706 Head Global Therapeutic Area Endocrinology + Cardio-Metabolic Care) |
endocrine/metabolic disease |
Merck (DE) (Group) |
Germany |
| Feige, Michael (Methrom 201301– Managing Director of Deutsche Methrom Prozessanalytik GmbH & Co KG) |
Managing Director |
Metrohm (Group) |
Germany |
| Feingold, Jay M. (Tagworks Pharmaceuticals 202306– CMO before Pyxis Oncology + ADC Tx + Daiichi Sankyo + Wyeth) |
Chief Medical Officer (CMO) |
Tagworks Pharmaceuticals B.V. |
Netherlands |
| Feist, Frank (BlueCatBio 201411– CEO + Founder before NobleGen Biosciences + BC + Olympus America + Polytechnos) |
Chief Executive Officer (CEO) |
BlueCatBio (BCB) (Group) |
United States (USA) |
| Felber, Erich (Biovertis 200409– CEO before Micromet) |
Chief Executive Officer (CEO) |
Deinove (Group) |
Austria |
| Felciano, Ramon (Ingenuity Systems 200705 Chief Technology Officer) |
n. a. |
Qiagen (Group) |
United States (USA) |
| Feldsine, Phil (BioControl Systems 201701 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
| Feleciano, Diogo R. (Booster Therapeutics 202410 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Booster Therapeutics GmbH |
Germany |
| Felgenhauer, Thomas (Pepperprint GmbH 2011– Head RnD before DKFZ) |
Research & Development Manager |
Pepperprint GmbH |
Germany |
| Felici, Antonio (Evotec 202210 VP Academic Partnerships) |
Business Development Manager / Strategy Manager |
Evotec (Group) |
Germany |
| Feling, Nicole (Köhl et Feling 201310 Partner + Bicoll PR) |
Public Relations Manager / Investor Relations Manager |
Innovation Industries (NL) |
Germany |
| Fellenberg, Friederike (NCT Heidelberg 201810 Press + Public Relations) |
Public Relations Manager / Investor Relations Manager |
National Center for Tumor Diseases (NCT) Heidelberg (Nationales Centrum für Tumorerkrankungen) |
Germany |
| Feller, Christine |
n. a. |
Baden-Württembergische Bank AG |
|
| Fellner, Peter (Acambis 200703 President) |
Board member, non-executive |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
| Felzmann, Thomas (AOP Orphan 201110 Managing Director + Founder of Activartis Biotech GmbH) |
Managing Director |
Élan (Group) |
Austria |
| Fenge, Christel (Sartorius 201201 VP Fermentation Technologies at Sartorius Stedim Biotech) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
| Fennell, Amber (Bielecka, Amber) (Consilium Strategic Communications 201307– Co-founder) |
Company Founder |
ICR (Group) |
United Kingdom (GB) |
| Fenzl, Edgar J. (FGK Clinical Research 201411 Managing Director + Co-founder) |
Managing Director |
FGK Clinical Research GmbH |
Germany |
| Feord, Rachel (Trophic Communications 202201) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Ferguson, Steve (Medix Biochemica 202201 CEO) |
Chief Executive Officer (CEO) |
Medix Biochemica (Group) |
Finland |
| Fernández, Javier (Vitro SA 201805 CEO) |
Chief Executive Officer (CEO) |
Vitro (ES) (Group) |
Spain (España) |
| Fernández-Alba, Amadeo Rodriguez (Univ Almería 201311 Prof + EURL-FV) |
Professor |
University of Almería (Universidad de Almería) |
Spain (España) |
| Ferneding, Stephan (Accurion GmbH 201602 Managing Director) |
Managing Director |
Accurion (Group) |
Germany |
| Ferreira, Isabel (Versameb 201910c– CBO before Roche Partnering + Prosensa) |
Chief Business Officer (CBO) |
Versameb AG |
Switzerland |
| Ferrer, Daniel Lopez (Thermo Fisher 202111 Director of Proteomics Program) |
n. a. |
Thermo Fisher (Group) |
United States (USA) |
| Fert, Vincent (HalioDx 201503– CEO + CO-founder before Ipsogen 200708– President + CEO) |
Chief Executive Officer (CEO) |
Veracyte (Group) |
France |
| Fertig, Niels (Nanion Technologies GmbH 201102 Managing Director CEO) |
Managing Director |
Nanion (Group) |
Germany |
| Fesik, Stephen W. (Vanderbilt Univ 200905– Professor before Abbott divisonal VP Cancer Research) |
Professor |
Abbott (Group) |
United States (USA) |
| Fesseler, Jana (BioRegio STERN 201802–) |
Cluster Manager |
BioRegio STERN Management GmbH |
Germany |
| Fest, Constantin (Merck (DE) 201301– Head Investor Relations joined 6/12 before Lanxess) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
| Festel, Gunter (Festel Capital 200501) |
n. a. |
Festel Capital |
Switzerland |
| Feuerstein, Marco (microDimensions GmbH 2011– Managing Director (COO) + Co-founder) |
Managing Director |
microDimensions GmbH |
Germany |
| Feuillet, Catherine (Bayer 201401 Head of Trait Research at Bayer CropScience) |
Researcher (industry) |
Bayer (Group) |
Germany |
| Feurstein, Burkhard (Oridis Biomarkers 201205– CEO + Partner at GCP gamma capital partners) |
Chief Executive Officer (CEO) |
Oridis Biomarkers GmbH |
Austria |
| Fewster, Martin (World Trade Group 201203 Marketing Manager at WTG Events) |
Sales Manager / Marketing Manager |
World Trade Group Ltd. (WTG) |
United Kingdom (GB) |
| Fibig, Andreas (IFF 201409– CEO before Bayer HealthCare Pharma + Pfizer + P&U + Boehringer Ingelheim) |
Chief Executive Officer (CEO) |
International Flavors & Fragrances Inc. (IFF) |
United States (USA) |
| Fichtinger, Luca (Kern Tec 202309 Managing Director + Co-Founder) |
Managing Director |
Kern Tec GmbH |
Austria |
| Fichtner, Caroline (High-Tech Gründerfonds 201002 Senior Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Fido, Markus (Vela Laboratories 201107 CEO) |
Chief Executive Officer (CEO) |
Vela pharmazeutische Entwicklung und Laboranalytik GmbH (Vela Laboratories) |
Austria |
| Fiebich, Bernd L. (VivaCell 201104 Managing Director) |
Managing Director |
VivaCell Biotechnology GmbH |
Germany |
| Fiebig, Heinz-Herbert (Oncotest GmbH 201108 Managing Director) |
Managing Director |
Charles River (Group) |
Germany |
| Fiedler, Susanne (Organon 202302 Chief Commercial Officer) |
Chief Commercial Officer (CCO) |
Organon (Group) |
United States (USA) |
| Fiedler, Ulrike (Coral BioNet 2000– Managing Director of Scil Proteins) |
Managing Director |
UV-Cap (Vetter family office) (Group) |
Germany |
| Fiehn, Hendrik (GeSiM 200809) |
Sales Manager / Marketing Manager |
GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH |
Germany |
| Field, Richard (CCS Cell Culture Service 201006 COO North America) |
Regional manager |
Evotec (Group) |
United States (USA) |
| Fields, Anne Marie (Rx Communications Group 202104 Managing Director) |
Public Relations Manager / Investor Relations Manager |
Rx Communications Group LLC (RxIR) |
United States (USA) |
| Fiessinger, Julian (Galenica 202408 Investor Relations + Corporate Finance) |
Public Relations Manager / Investor Relations Manager |
Galenica (Group) |
Switzerland |
| Fietz, Carsten (c-LEcta GmbH 201509– Head Finance + Administration before CFO) |
Financial Manager (CFO, Financial Director, etc.) |
Kerry Group (Group) |
Germany |
| Figueiredo, Constanca Ferreira de (Allogenetics 202409 Co-Founder) |
Company Founder |
Allogenetics GmbH |
Germany |
| Figueiredo, José Fernando (EU (govt) 202203 EIC Fund Investment Committee Member) |
n. a. |
EU (govt) |
EU (European Union) |
| Figulla, Laura (Mbiomics 202303 COE + Co-Founder formerly Coramaze Technologies 201401– Managing Director + Co-founder) |
Managing Director |
Mbiomics GmbH |
Germany |
| Filerman, Marc (Germany (govt) 201906– CEO of German Accelerator Life Sciences before Secora + MGH) |
Cluster Manager |
Start2 Group (Group) |
United States (USA) |
| Filliol, Olivier (Mettler Toledo 199801– CEO) |
Chief Executive Officer (CEO) |
Mettler-Toledo (Mettler Toledo) (Group) |
Switzerland |
| Finan, Peter (Epidarex Capital 2014– Venture Partner + Karus Therapeutics 201410– Head of Biology before Novartis) |
Venture Partner |
Karus Therapeutics Ltd. |
United Kingdom (GB) |
| Finbow, Anthony (Eagle Genomics 201501– CEO before Executive Chairman) |
Chief Executive Officer (CEO) |
Eagle Genomics Ltd. |
United Kingdom (GB) |
| Fink, Klaus (Eppendorf 2006 CEO joined 1989) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
| Fink, Thomas (Portus Corporate Finance 200804 Managing Director + CCM 200804 Managing Director) |
Managing Director |
CCM Columbus Capital Management GmbH |
Germany |
| Finkbeiner, Petra (PANATecs 201003) |
Sales Manager / Marketing Manager |
Zukunftsfonds Heilbronn (Group) |
Germany |
| Finke, Franziska (LenioBio 202203 CFO) |
Chief Financial Officer (CFO) |
LenioBio GmbH |
Germany |
| Finke, Gandolf (Fosanis GmbH 201908 Managing Director + Co-Founder) |
Managing Director |
Fosanis GmbH |
Germany |
| Firmenich, Patrick (Firmenich 202205 Chairman) |
Board member, non-executive |
Firmenich (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 21 22 23 ... 93 94 95 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
